Turnstone Biologics' Series A Round

Turnstone Biologics raised a round of funding on October 28, 2015.

Turnstone Biologics is a biotechnology company focused on developing novel oncolytic viral immunotherapies for cancer. Turnstone's therapeutic platform is a first-in-class tumor-targeted oncolytic vac…

Articles about Turnstone Biologics' Series A Round: